Stay updated on Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Sign up to get notified when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:45:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays the study record, including its treatment plan, eligibility criteria, locations, outcome measures, results information, and study documents.
    Difference
    61%
    Check dated 2026-10-26T14:22:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:47.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:40:18.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the expected study content, indicating restricted access to the record.
    Difference
    19%
    Check dated 2026-09-21T22:21:41.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The site footer now shows Revision: v3.6.6, replacing the previous revision. This indicates a minor deployment/version label update.
    Difference
    0.1%
    Check dated 2026-08-31T16:49:16.000Z thumbnail image

Stay in the know with updates to Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nal-Irinotecan & Nivolumab in Biliary Cancer Clinical Trial page.